Cullinan Therapeutics Inc (CGEM)
$15.03 -2.72% Close Oct 30, 2026 Live
Cullinan Therapeutics stock today
Cullinan Therapeutics closed at $15.03 on October 30, 2026, down 2.72% on the day. Over the past year it returned +98.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $924 million.
$10.00$15.00$20.00
NovJan 2026MarMayJulSep
| Period | CGEM | S&P 500 (SPY) |
|---|---|---|
| 1 month | -2.1% | -0.9% |
| 3 months | -14.2% | +2.1% |
| Year to date | +45.2% | +11.7% |
| 1 year | +98.8% | +12.4% |
| 3 years | +73.0% | +88.5% |
| 5 years | -32.4% | +76.0% |
Key statistics
- Market value
- $924M
- 52-week range
- $7.19 to $22.95
- Next report
- Nov 14, 2026
About Cullinan Therapeutics
Develops immunotherapy and oncology therapeutics for cancer treatment.
Sector: Health Care
More on Cullinan Therapeutics
- Returns: what $1,000 became$1,000 five years ago is $676.42 today
No forecast, no recommendation. This page describes Cullinan Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.